Government Has Granted Permission To Serum Institute Of India To Manufacture Vaccine And Stockpile It For Future Use

According to the reports coming from serum Institute of India that COVISHIELD will be commercialized once trial are proven successful and requisite regulatory approval are in place. Phase 3 trials for Oxford AstraZeneca vaccine are underway. Only once vaccine is proven immunogenic and efficacious,SII will confirm its availability officially. 

According to the reports coming in the Serum Institute of India clarifies that the current claim over COVISHIELD's availability in the media are completely false and conjectural. According to the reports also coming in that presently government has granted SII permission to only manufacture the vaccine and stockpile it for future use.